AG
ABMD

Aperio Group’s Abiomed Inc ABMD Stock Holding History

Aperio Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$7.83M Sell
24,137
-1,021
-4% -$282K 0.02% 647
2020
Q3 		$6.97M Buy
25,158
+993
+4% +$286K 0.02% 616
2020
Q2 		$5.84M Sell
24,165
-3,596
-13% -$722K 0.02% 674
2020
Q1 		$4.03M Buy
27,761
+11,114
+67% +$1.84M 0.02% 742
2019
Q4 		$2.84M Sell
16,647
-633
-4% -$117K 0.01% 944
2019
Q3 		$3.07M Sell
17,280
-2,556
-13% -$553K 0.01% 877
2019
Q2 		$5.17M Sell
19,836
-4,217
-18% -$1.12M 0.02% 702
2019
Q1 		$6.87M Buy
24,053
+203
+0.9% +$67.5K 0.03% 577
2018
Q4 		$7.75M Sell
23,850
-733
-3% -$255K 0.04% 483
2018
Q3 		$11.1M Buy
24,583
+3,016
+14% +$1.19M 0.05% 410
2018
Q2 		$8.82M Buy
21,567
+1,566
+8% +$567K 0.04% 478
2018
Q1 		$5.82M Buy
20,001
+2,295
+13% +$582K 0.03% 600
2017
Q4 		$3.32M Buy
17,706
+3,977
+29% +$743K 0.02% 797
2017
Q3 		$2.31M Buy
13,729
+531
+4% +$80.3K 0.01% 881
2017
Q2 		$1.89M Buy
13,198
+853
+7% +$115K 0.01% 934
2017
Q1 		$1.54M Sell
12,345
-1,330
-10% -$154K 0.01% 959
2016
Q4 		$1.54M Sell
13,675
-2,402
-15% -$278K 0.01% 927
2016
Q3 		$2.07M Buy
16,077
+4,048
+34% +$485K 0.02% 824
2016
Q2 		$1.31M Buy
12,029
+4,784
+66% +$476K 0.01% 957
2016
Q1 		$687K Buy
7,245
+1,001
+16% +$84.5K 0.01% 1214
2015
Q4 		$564K Buy
6,244
+79
+1% +$6.7K 0.01% 1271
2015
Q3 		$572K Buy
6,165
+335
+6% +$29.5K 0.01% 1226
2015
Q2 		$383K Buy
5,830
+509
+10% +$33.8K ﹤0.01% 1478
2015
Q1 		$381K Buy
+5,321
New +$289K ﹤0.01% 1428

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Aperio Group's ABMD Position: Q4 2020 in Review

Aperio Group reduced its Abiomed Inc (ABMD) stake by 4.1% in Q4 2020, selling an estimated $282K and leaving 24,137 shares worth $7.83M. The position accounts for 0.02% of the portfolio, ranked #647.

Aperio Group first reported a position in ABMD in Q1 2015 and has held it in 24 quarters since. The position peaked at $11.1M in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Aperio Group held 24,137 shares of Abiomed Inc worth $7.83M as of Q4 2020.
  • Aperio Group sold 1,021 Abiomed Inc shares in Q4 2020, an estimated $282K.
  • Abiomed Inc made up 0.02% of Aperio Group's portfolio in Q4 2020, its #647 holding.
  • Aperio Group first reported a position in Abiomed Inc in Q1 2015 and has held it in 24 quarters since.
  • Aperio Group's Abiomed Inc position peaked at $11.1M in Q3 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.